EANS-Adhoc: Sartorius AG rearranges Executive Board

--------------------------------------------------------------------------------
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
adhoc with the aim of a Europe-wide distribution. The issuer is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

24.07.2009

The Supervisory Board of the Sartorius AG decided unanimously in a
meeting held on July 24th, 2009, to appoint Reinhard Vogt and Jörg
Pfirrmann with immediate effect as new members of the Executive
Board. At the same time the Supervisory Board and Dr. Günther Maaz
amicably agreed by mutual consent that Dr. Maaz, who will turn 60 in
September 2009, will resign from his position on the Executive Board
of the Sartorius AG. The Supervisory Board thanks Dr. Maaz for his
accomplishments for the benefit of the company over more than three
decades in various positions, at last as a member of the Executive
Board since 2002, and wishes him all the best for the future.

Within the new constellation of the Executive Board, every Member of
the Board has cross-divisional responsibilities. Reinhard Vogt (53)
will be in charge of Marketing, Sales and Service, while Jörg
Pfirrmann (36) will take over the responsibility for Finance, IT and
General Administration. The CEO, Dr. Joachim Kreuzburg (44), will be
in charge of Operations, Legal Affairs, Internal Auditing and
Corporate Communications as well as Human Resources and therefore
will also take over the function of the Executive for Labor
Relations. At the same time he will keep his current positions as the
Chairman of the Board of Directors and the CEO of the Sartorius
Subgroup Sartorius Stedim Biotech.

Reinhard Vogt, who has been with the Sartorius Group since 1983, has
essentially shaped the strategic development of the Biotechnology
Division and successfully achieved growth of sales revenues and
profits. He will retain his present position as Executive Vice
President for Marketing, Sales and Service of Sartorius Stedim
Biotech.

Jörg Pfirrmann works since 1999 for Sartorius and was previously
globally responsible for Group Finance. In the last years he has
played a major part in orchestrating the success of key restructuring
processes and acquisition projects of the Sartorius Group.

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Sartorius AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Andreas Wiederhold

Team Leader Treasury & Investor Relations

Telefon: +49 (0)551 308-1668

E-Mail: andreas.wiederhold@sartorius.com

Branche: Biotechnology
ISIN: DE0007165607
WKN: 716560
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade